AMY MAHAR: Open Payments
NPI 1750352480 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 15 payments from 9 companies in 2025. Trend: 2023 $249 · 2024 $533 · 2025 $372
Food & beverage: $330Education: $43
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $179 |
| Mannkind Corporation | 1 | $43 |
| Medtronic, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| Corcept Therapeutics | 1 | $14 |
Products named: FREESTYLE LIBRE 3, AFREZZA, MINIMED 780G, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, EVENITY, MOUNJARO, Korlym.
Industry payments across NE — which companies pay providers there.
